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Introduction
Myotonic dystrophy type 1 (DM1, OMIM 160900) is the most frequent form of inherited muscular dystrophy in adulthood, with a prevalence of about 1:8000 [1] . The adult-onset form is the most prevalent, with common clinical exacerbation in the second or third decade of life. Clinical manifestations of adult-onset DM1 involve a broad spectrum of systemic complications, such as cardiac conduction abnormalities and cardiomyopathy, cataract, central nervous system dysfunction, gastrointestinal symptoms, and endocrine abnormalities [1] [2] [3] [4] . The main features at the skeletal muscle level are muscle weakness and grip and percussion myotonia [1] . Distal muscles are generally more compromised than the proximal ones [1, 5] .
The mechanisms for muscle weakness, which involves difficulties to perform fine tasks with the hands, foot drop, and facial muscles ptosis, are not fully elucidated. Experimental evidence demonstrates that an alteration in the splicing of several proteins involved in Ca 2+ homeostasis and in excitation-contraction coupling mechanisms may play a pivotal role [6] [7] [8] [9] [10] . Myotonia is characterised by a state of pathologically enhanced muscle excitability, in which involuntary trains of action potentials cause a delay in muscle relaxation after contraction [11] . This phenomenon has been associated to the alternative splicing of chloride channels at the muscle fibre level, which determines an alteration of membrane excitability [11] . Altogether, these skeletal muscle alterations in DM1 cause impairments in the cascade of the events involved in muscle contraction and relaxation.
MMG generation, as shown in Fig. 1 : (i) the gross lateral movement of the contracting fibres at the beginning of contraction (MMG complex), generated by the shortening of contractile elements before the slack of the elastic-connective tissue has been fully taken up, and F has been transmitted to the tendon insertion point [15] ; (ii) the subsequent vibrations at the resonance frequency of the muscle (MMG ripple), reflecting the dimensional changes of the active fibres propagating towards the muscle surface [19] [20] [21] [22] ; and (iii) the gross lateral movement of the muscle at the end of contraction (R-MMG complex), due to the maximum acceleration of muscle surface caused by cross-bridges detachment and series elastic components (SEC) detensioning [23, 24] .
During the on-phase of muscle contraction, the time lag between the onset of muscle electrical activation (EMG onset) and the beginning of F generation (F onset) has been traditionally defined as the electromechanical delay [25] . This time lag includes the electrochemical and mechanical events from motor unit action potential propagation at the sarcolemmal level to force transmission at the tendon insertion point. Similarly, a latency between the cessation of muscle electrical activation (end of EMG signal) and the beginning of F decay has been assessed during the relaxation phase [26] , and defined as the relaxation electromechanical delay [27] . This latency spans from the cessation of sarcolemmal electrical activation to the cross-bridges and SEC return toward their pre-contraction status.
When also MMG is recorded, the three signals allow the partitioning of the total electromechanical delay (Delay TOT ) into (i) a mainly electrochemical component, which includes the events from the propagation of the motor unit action potential at the sarcolemmal level to myosin head rotation and pressure wave transmission to the skin surface [28, 29] , and (ii) a mainly mechanical component, which reasonably provides a potential index of the time required for taking up the muscle-tendon unit slack, before F transmission becomes efficient at the tendon insertion point [12] [13] [14] 16] . When the muscle is electrically activated, the simultaneous recording also of the stimulation current (Stim) offers an additional Delay TOT component between Stim and EMG onset, related to the presynaptic and synaptic events [16] .
At the end of a voluntary contraction, the total electromechanical delay during relaxation (RDelay TOT ) can be partitioned with the addition of MMG in one mainly electrochemical and three consecutive mainly mechanical components. The first component includes the events from the cessation of the electrical activation of the sarcolemma and the beginning of Ca 2+ reuptake in the sarcoplasmic reticulum to the transition of cross-bridges from force-generating to non-forcegenerating status, together with the pressure wave transmission to the skin surface. The second component comprises the beginning of the rapid change in sarcomere length and the increase in the detachment rate of cross-bridges. The third component incorporates the main phase of cross-bridge detachment and SEC relaxation. Lastly, the fourth component includes the time taken by the crossbridges and SEC to return toward their pre-contraction status [15, 17, 18] .
A similar approach, with the use of high frame rate ultrasound, has been recently proposed in patients with Duchenne dystrophy during contraction [30] . A lengthening of the overall delay due to mechanical component expansion was clearly observed.
In clinical settings, myotonia and muscle weakness are usually determined on patients with DM1 
Experimental design
Patients with DM1 and HC reported to the laboratory two times. During the first visit, participants were familiarized with the experimental set-up and procedures. On a subsequent day, participants reported to the laboratory for a second visit for testing procedures, involving the assessment of maximum electrically evoked and voluntary strength and of inter-and intra-session reliability.
Experimental procedures
All experiments were carried out in a laboratory at a constant temperature of 22 ± 1 °C and relative humidity of 50 ± 5%. Participants were asked to abstain from caffeinated or other similar beverages in the 24 h preceding the tests, and to refrain from any heavy physical exercise with their lower limbs in the 48 h prior to the study.
During the first visit, participants were instructed to contract and fully relax the investigated muscle For both muscles (TA and VL), the EMG array was placed over the muscle belly near the point of maximum skin displacement during contraction, along the direction of the muscle fibres, with the EMG electrodes positioned perpendicular to the major axes of the fibres between the tendon and the motor point, in accordance with the European recommendations for surface EMG [34] .
Neuromuscular electrical stimulation was delivered to TA and VL in monopolar technique by an electrical stimulator (mod. St-Pro Multichannel Programmable Neuromuscular Stimulator, LiSin, Turin, Italy). For TA activation, the receiving electrode (130 x 100 mm) was positioned at the third distal of the leg, whereas the stimulating electrode (90 x 40 mm) was placed over the most proximal motor point of the muscle. For VL activation, the receiving electrode was positioned at the third proximal of the thigh and the stimulating electrode was placed over the most proximal motor point of the muscle. A set of brief 2-Hz stimulations of increasing amplitude was administered to determine the maximum compound motor unit stimulus. After the stimulus that elicited the maximal peak-to-peak M-wave was identified, participants rested for 5 min. Then, a set of three tetanic stimulations, consisting of a train of pulses (wave shape: biphasic; pulse duration: 304 s; stimulation frequency: 50 Hz; current amplitude: 110% of the maximum compound motor unit stimulus; duration: 2s) was delivered. During stimulations, participants were instructed to maintain the muscles of the lower limb as relaxed as possible. The lack of activation of the antagonist muscles (biceps femoris and medial gastrocnemius muscles for VL and TA, respectively) was monitored during contraction by an EMG linear array (mod. ELSCH004, 45 mm x 20 mm; electrode 2 mm x 1 mm; inter-electrode distance 10 mm; OtBioelettronica, Turin, Italy).
Measurements obtained from the three trials were used for intra-session reliability determination.
To assess inter-session reliability, EMG, MMG and stimulation electrodes were removed after the first set of measurements (S A ) and repositioned after 10 minutes. Thereafter, all procedures were repeated again (S B ). Maps with some skin identification points (moles, angiomas, and scars) and with the position of the EMG-MMG integrated probe on the TA and VL were drawn on a transparency to allow repeated measurements from the same muscle area on different sessions.
Data analysis
The signals acquired (Stim, EMG, MMG, and F) were analysed off-line by a custom-built routine of a commercially available software (Labview 7.1. National Instruments, Austin, TX, USA).
EMG, MMG and F signals analysis.
Time domain analysis of the EMG signal allowed the calculation of the root mean square (RMS) from epochs of 1 s, corresponding to the central part of the F plateau reached during each contraction. From the MMG signal, the maximum displacement during the MMG (MMG p-p ) and R-MMG (R-MMG p-p ) complex were determined. The pF and MVC were assessed as the highest level of F achieved during the three trials of electrically evoked and voluntary contractions, respectively.
Delays calculation
Delays identification in a representative participant is given in Fig. 3 . The criteria used to identify the reference points for delays components have been fully reported in previous investigations [14, 16, 18] . Briefly, during the electrically evoked contraction Delay TOT was partitioned into three 
Statistical analysis
Raw data were analysed using a statistical software package (IBM SPSS Statistics v. 22, Armonk, NY, USA). To check the normal distribution of the sampling, a Shapiro-Wilk test was applied.
Based on previous investigations by our group [35, 36] and on preliminary data, a sample size of 13 participants was selected to ensure a statistical power higher than 0. [38] . The level of significance was set at α<0.05. Unless otherwise stated, the results are expressed as mean ± standard error (SE).
Results
None of the participants complained for any heavy discomfort or pain during testing procedures.
During S A and S B , one-way ANOVA did not disclose significant differences among the three trials within each session for EMG, MMG and F parameters calculated in TA and VL during electrically evoked and voluntary contractions. The results were therefore pooled and used for further analysis.
Reliability and sensitivity of the measurements
ICC and SEM% for the investigated variables are reported in Tables 1-4 for HC and DM1. Intraand inter-session reliability in HC resulted always from high to very high, with ICC ranging from 0.80 to 0.99. SEM% was between 1% and 7% of the relative mean value. Similarly, ICC in DM1 ranged from 0.79 to 0.99, with SEM% between 1% and 13%.
The MDC 95 % calculated in HC and the percentage difference between HC and DM1 are presented in Table 5 . All the variables showed relative differences between DM1 and HC higher than those required by MDC 95 %.
EMG, MMG and F parameters
The differences between DM1 and HC in EMG, MMG and F parameters are presented in Fig 4. EMG RMS (panel A) was significantly lower in DM1 than HC in both TA (p<0. 
Delays
The relative duration of Delay TOT and R-Delay TOT components during electrically evoked and voluntary contractions is reported in Fig. 5 
Discussion
The novel findings of the study were that: (i) intra-and inter-session reliability of delay components measurement in patients with DM1 was always from high to very high, with adequate levels of sensitivity; and (ii) all components of the delays in both the contraction and relaxation phases were longer in patients with DM1 than in HC. These results suggest that DM1 affected the duration of both the electrochemical and the mechanical events underpinning muscle contraction and relaxation. Noteworthy, given the very high level of reliability and sensitivity, this EMG, MMG, and F combined approach may be proposed as a valid means to investigate muscle contraction and relaxation characteristics in patients with DM1.
Reliability and sensitivity
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The reliability analysis provided similar ICC values between patients with DM1 and HC. Reliability was always from high to very high in both groups, thus preparing the way to the applicability of this combined approach also to clinical settings.
In previous studies on HC under electrically evoked contraction, ICC values ranged from 0.919 to 0.989 and from 0.781 to 0.981 for intra-and inter-session reliability, respectively, for the delay components during the on-phase of muscle contraction [16] . Under voluntary contraction, only inter-session reliability analysis on delays components has been so far proposed, with ICC values ranging from 0.994 to 0.997 [14] . During relaxation after electrically evoked muscle activation, inter-session reliability provided ICC values ranging from 0.794 to 0.949 [17] , while after voluntary activation only inter-day reliability was investigated, with ICC values ranging from 0.921 to 0.943 [18] . High levels of inter-operator reliability was also reported in a previous investigation, in which a similar analysis was conducted [16] . These previous findings are perfectly in line with those of the present investigation in HC (see Tables 1 and 2 ), thus clearly showing that this approach can provide reliable intra-and inter-session delay measurements also in patients with DM1. It must be noted, though, that previous studies investigated different skeletal muscles, such as the biceps brachii [14, 18] or gastrocnemius medialis [16, 17] muscles. Therefore, future studies in this direction to broaden delays reliability in different muscles may be required for both patients with DM1 and HC.
The difference in delays assessment between patients with DM1 and HC retrieved in the present investigation were larger than those requested by the MDC 95% , thus indicating an adequate level of sensitivity. High intra-and inter-session reliability and sensitivity levels are two crucial requirements to introduce this approach in a clinical setting. Therefore, the present study represents a first solid step toward this direction.
EMG, MMG, and F parameters
In agreement with previous investigations [35, 36] , maximum electrically evoked and voluntary strength were significantly lower in DM1 than in HC in both muscles. Lower EMG and MMG amplitude parameters values accompanied this force deficit in patients with DM1. Collectively, the DM1-induced alteration in Ca 2+ release, the reduction in the number of efficient motor units, as witnessed by the lower EMG and MMG amplitude, and the increased fibrosis and adipose deposition may all concur to explain the reduction in force [5, 35, 36] .
During relaxation, R-MMG p-p was lower in DM1 by about 46% and 61% in TA and VL, respectively, compared to controls, indicating a slower maximum acceleration of the muscle surface toward its resting position. This finding well agrees with the myotonic phenomenon, which is typically retrieved in patients with DM1. Moreover, R-MMG p-p was also suggested to correlate with Ca 2+ reuptake [39] . Thus, an impairment also in this mechanism cannot be completely ruled out and may need further investigation.
Delays during muscle contraction
Delay TOT was longer in DM1 than in HC under both experimental conditions. With the only exception of t Stim-EMG during VL contraction, all the components contributed to the lengthening of Delay TOT .
t Stim-EMG, reflecting the time lag between the origin of the action potential at the axonal level and the action potential propagation along the sarcolemma, thus including also the synaptic latency [16] , was about 33% longer in DM1 than HC in TA. A longer duration of this component may suggest that an alteration of some electrochemical process involved in the synaptic latency may have occurred with DM1, at least in distal muscles, which are usually more affected than the proximal ones [1, 5] .
The subsequent component, t EMG-MMG, includes events that are mainly electrochemical in nature, spanning from the propagation of the motor unit action potential at the sarcolemmal level to myosin head rotation, together with the pressure wave transmission to the skin surface detected by MMG (Hufschmidt 1985; Petitjean et al. 1998 ). The longer t EMG-MMG in DM1 may be explained by the alteration in the splicing of several proteins, such as SERCA1 and CACNA1S, involved in Ca 2+ homeostasis and in excitation-contraction coupling mechanism [6] [7] [8] [9] [10] thus possibly leading to a lengthened duration of the dihydropyridine and ryanodine receptors interaction, Ca 2+ release by sarcoplasmic reticulum, and troponin activation [9, 10, 35] .
t MMG-F is the Delay TOT component mainly reflecting the mechanical events involved in muscle contraction. This delay may provide a potential index of the time required for taking up the muscletendon unit slack, before F transmission becomes efficient at the tendon insertion point [12] [13] [14] . The longer duration of t MMG-F in DM1 may be suggestive of an alteration of the F transmission to the tendon insertion point. Likely, the modification occurring in DM1 at the muscle level, such as fibrosis and adipose deposition [5] , may have reduced the whole efficiency in SEC tensioning.
Delays during muscle relaxation
R-Delay TOT was significantly longer in DM1 than HC by about 50%. Both the mainly electrochemical and the three mechanical components contributed to this difference between groups. As previously mentioned (see Introduction), myotonia consists in repetitive firing of some fibres due to an alternative splicing of chloride channels at the muscle fibre level that causes an increase in their membrane excitability [11] . This phenomenon leads to the inability of the muscle to fully relax in a certain period [11] , and can play a pivotal role in explaining the lengthening of RDelay TOT .
R-t EMG-F, the mainly electrochemical component of R-Delay TOT , likely includes the beginning of Ca 2+ reuptake in the sarcoplasmic reticulum and the transition of cross-bridges from a forcegenerating to a non-force-generating status [17, 18, 40, 41] . The previously mentioned alteration in chloride channels excitability and in SERCA1 and CACNA1S splicing, may have delayed Ca 2+ reuptake in the sarcoplasmic reticulum, [11] , and in turn lengthened the mainly electrochemical RDelay TOT component.
The myotonic phenomenon, which per se has an electrical origin, could provide a mechanistic insight also for the behaviour of the muscle-tendon unit during the mainly mechanical phases of muscle relaxation. Previous studies, indeed, focusing on HC, suggested that the mainly mechanical components of R-Delay TOT could reflect (i) the beginning of the rapid change in sarcomere length and the increase in the detachment rate of cross-bridges (R-t F-MMG p-p ); (ii) the main phase of the detachment of cross-bridges and SEC relaxation (R-t MMG p-p ); and (iii) the final return of crossbridges and SEC to their pre-contraction status, respectively (R-t MMG-F end ) [17, 18] . This cascade of events is typical of a physiologic muscle relaxation. If an involuntary train of action potentials occurs during the last phases of muscle relaxation (i.e. when F has already began to decrease), the cross-bridges and SEC dynamics would be strongly affected by this phenomenon.
This, in turn, would lead to an overall lengthening of the mainly mechanical components of RDelay TOT .
Some authors hypothesized two different mechanisms to describe the cross-bridges and SEC behaviour of a muscle presenting the myotonic phenomenon [5, 42] . The first mechanism implies two populations of muscle fibres: (i) normally relaxing fibres, and (ii) slowly relaxing fibres. As these two groups of fibres are relaxing in parallel, their forces sum, accounting for an abrupt transition between rapid and delayed relaxation. The normally relaxing fibres drive the initial relaxation phase, but once they have fully relaxed, the slowly relaxing fibres dominate and drive the terminal relaxation phase [5] . The second mechanism is related to SEC elastic properties [42] .
Under isometric condition, SECs are stretched when myofilaments contract. The resultant elastic force, acting in a direction opposite to that of the myofilaments, is expected to be greatest during a maximum contraction, i.e., when cross-bridges are mostly engaged and can therefore overcome the initial "myotonic" forces during the first phase of muscle relaxation, when the cross-bridges begin to disengage. By contrast, elastic forces, which are attenuated when myofilaments return to their resting state, would yield to the "myotonic" forces in the last phase of relaxation [42] .
Lastly, also the muscle fibres rearrangement in DM1 [1, 5] , which includes basophilic regenerating fibres, splitting fibres, fibrosis and adipose deposition, may also be proposed as further mechanisms to explain the lengthening of the mainly mechanical components of R-Delay TOT .
Conclusions
Our findings show that the EMG, MMG and F combined approach for Delay TOT and R-Delay TOT components provides reliable and sensitive measurements also in DM1 population. The differences between patients with DM1 and HC in Delay TOT and R-Delay TOT components, together with the high reliability levels, suggest that the proposed EMG, MMG and F combined approach may be used as a valid tool to assess the level of neuromuscular dysfunction in this pathology. This means may be used also to assess the degree of skeletal muscle impairment during the natural history of the disease, and to follow the efficacy of pharmacological (e.g., mexiletine or the upcoming trial with ISIS-DMPKrx) or non-pharmacological interventions in patients with DM1. 
